J&J’s Xarelto Wins Favorable Committee Vote, But Will FDA Delay Approval For ATLAS Data?

Cedars-Sinai cardiologist Kaul and Public Citizen’s Wolfe are the two "no" votes in 15-2 panel nod for the anti-coagulant.